bion3.com Report : Visit Site


  • Ranking Alexa Global: # 3,698,270

    Server:Apache...

    The main IP address: 52.28.35.66,Your server Germany,Frankfurt am Main ISP:Amazon Technologies Inc.  TLD:com CountryCode:DE

    The description :we put our patients at the center of everything they do – with the goal to help to improve, prolong, create and make a difference to millions of lives....

    This report updates in 09-Sep-2018

Created Date:2000-09-20
Changed Date:2017-06-22
Expires Date:2017-09-20

Technical data of the bion3.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host bion3.com. Currently, hosted in Germany and its service provider is Amazon Technologies Inc. .

Latitude: 50.115520477295
Longitude: 8.6841697692871
Country: Germany (DE)
City: Frankfurt am Main
Region: Hessen
ISP: Amazon Technologies Inc.

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

Content-Length:31347
Content-Encoding:gzip
Accept-Ranges:bytes
Vary:Accept-Encoding
Server:Apache
Last-Modified:Fri, 07 Sep 2018 14:56:29 GMT
Connection:keep-alive
ETag:"375b6-5754936639a7f"
Date:Sun, 09 Sep 2018 02:55:09 GMT
X-Frame-Options:SAMEORIGIN
Content-Type:text/html; charset=UTF-8

DNS

soa:ns1.brandshelter.com. tech.brandshelter.com. 2018080200 10800 3600 604800 300
ns:ns5.brandshelter.us.
ns3.brandshelter.info.
ns4.brandshelter.net.
ns2.brandshelter.de.
ns1.brandshelter.com.
ipv4:IP:52.28.35.66
ASN:16509
OWNER:AMAZON-02 - Amazon.com, Inc., US
Country:US
mx:MX preference = 10, mail exchanger = wingate.merck.de.
MX preference = 20, mail exchanger = igngate.merck.de.
MX preference = 10, mail exchanger = inetgate.merck.de.

HtmlToText

you are using an outdated browser. please upgrade your browser to improve your experience. select your country global africa asia europe latin america north america oceania algeria angola benin botswana burkina faso burundi cabo verde cameroon central african republic chad comoros côte d'ivoire democratic republic of the congo djibouti egypt eritrea ethiopia gabon gambia ghana guinea guinea bissau kenya lesotho libya madagascar malawi mali mauritania mauritius morocco mozambique namibia niger nigeria republic of the congo rwanda sao tome and principe senegal seychelles sierra leone somalia south africa south sudan sudan swaziland tanzania togo tunisia uganda zambia zimbabwe afghanistan armenia azerbaijan bahrain bangladesh bhutan brunei cambodia china india indonesia iran iraq israel japan jordan kazakhstan kuwait kyrgyzstan laos lebanon malaysia maldives mongolia myanmar nepal oman pakistan palestine philippines qatar saudi arabia singapore south korea sri lanka syria taiwan tajikistan thailand timor leste turkey turkmenistan united arab emirates uzbekistan vietnam yemen albania andorra austria belarus belgium bosnia and herzegovina bulgaria croatia cyprus czech republic denmark estonia finland france georgia germany greece hungary iceland ireland italy kosovo latvia liechtenstein lithuania luxembourg macedonia malta moldova monaco montenegro netherlands norway poland portugal romania russia san marino serbia slovakia slovenia spain sweden switzerland ukraine united kingdom vatican city argentina bolivia brazil chile colombia ecuador paraguay peru uruguay venezuela canada mexico united states of america australia fiji kiribati marshall islands micronesia nauru new zealand palau papua new guinea samoa solomon islands tonga tuvalu vanuatu global company who we are 350-year anniversary partnering responsibility media news contact us expertise healthcare healthcare portfolio allergen immunotherapy* consumer health* fertility general medicine neurology & immunology life science clinical and diagnostics emerging biotech environmental testing food and beverage government & academic research industrial pharma and biopharma manufacturing pharmaceutical research pharma quality control performance materials architecture automotive cosmetics displays effect pigments functional solutions optoelectronics semiconductors research our r&d approach innovation center open innovation biopharma-pipeline careers why work with us? benefits students professionals faqs job search investors why invest events & presentations reports & financials shares & bonds corporate governance ir contact & services show all results show all results company expertise research careers investors global en back company who we are 350-year anniversary partnering responsibility media news contact us back expertise healthcare healthcare portfolio allergen immunotherapy* consumer health* fertility general medicine neurology & immunology life science clinical and diagnostics emerging biotech environmental testing food and beverage government & academic research industrial pharma and biopharma manufacturing pharmaceutical research pharma quality control performance materials architecture automotive cosmetics displays effect pigments functional solutions optoelectronics semiconductors back research our r&d approach innovation center open innovation biopharma-pipeline back careers why work with us? benefits students professionals faqs job search back investors why invest events & presentations reports & financials shares & bonds corporate governance ir contact & services company who we are healthcare the work of our healthcare business can help to make a difference to millions of lives. we put our patients at the center of everything we do. share our healthcare business aims to change lives with a holistic approach, we design and develop medicines and intelligent devices that strive to provide ongoing care for patients beyond their treatment. this includes medications to treat conditions such as cancer or multiple sclerosis (ms). for example, we offer an injection device and disease monitoring software outside usa and canada that allow patients with ms to self-inject their medicine and track its administration. with cancer, our precise approach uses biomarkers that can match potential treatment to individual patients. our goal is to support people at various stages of life. we have helped many women and couples achieve their dream of having a baby. as a global market leader in fertility treatments, we do what we do with passion – and we think further ahead. that’s why we complemented our legacy in fertility drug treatments with the launch of a dedicated fertility technologies unit to help improve treatment outcomes in the lab. see all therapeutic areas of our business below : our therapeutic areas allergies allergies outside the united states and canada, we are a leader in allergen immunotherapy and our portfolio encompasses a diverse spectrum of approved allergen products. consumer health consumer health we also develop high-quality products with the aim of supporting every member of your family. our over-the-counter brands are household names in many regions and can be found in pharmacies around the world outside the united states and canada. they are trusted products that protect and support people at every stage of life. for example, we were the first company to develop metafolin® – integral to femibion®. metafolin® is a specific formulation of folate developed and patented by us that does not have to be converted in the body but is available directly.[1] its nutrients support women during the exciting journey before, during and after pregnancy. our bion® product has become the supplement of choice for multivitamins, and offers everyday immune support to the whole family. our renowned seven seas® brand supports brain health, vision, heart health and general well-being. one of our over-the-counter products has even been tried and tested in space! nasivin® was included by nasa on the apollo 11 mission in 1969. fertility fertility our goal is to provide healthcare professionals and patients with a variety of innovative treatment options and devices as well as advanced fertility technologies. general medicine general medicine outside the united states and canada, we offer medications for the treatment of type 2 diabetes, cardiovascular and thyroid diseases. each year, about 59 million patients are treated with our drugs in these therapeutic areas. neurodegenerative diseases neurodegenerative diseases we help to treat relapsing forms of multiple sclerosis (ms), one of the most common neurological diseases among young adults. currently we are also developing new medications to offer a variety of treatment options. oncology oncology we offer a treatment for a rare form of skin cancer and bladder cancer with one of our oncology drugs. outside the united states and canada, we offer a treatment for colorectal cancer and carcinoma of the head and neck. building on new discoveries made by our research team, we continue to do innovative work in the field of immuno-oncology. [1] reference http://www.emdmillipore.com/us/en/products/small-molecule-pharmaceuticals/bulk-api/folates/metafolin/key-benefits/83ob.qb.mzeaaafntwxitht_,nav?bd=1 ; last accessed may 9th company careers stories press research responsibility contact us healthcare healthcare expertise overview consumer health fertility neurology & immunology life science clinical & diagnostics emerging biotech environmental testing food & beverage government & academic research industrial pharma & biopharma manufacturing pharmaceutical research pharma qc performance materials architecture automotive cosmetics displays effect pigments functional solutions optoelectronics semiconductors healthcare healthcare expertise overview consumer health fertility neurology & immunology life

URL analysis for bion3.com


https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/industrial.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/research/our-approach-to-research-and-development.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/semiconductors.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/investors/reports-and-financials.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/company/who-we-are.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/automotive.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/pharma-and-biopharma-manufacturing.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/pharma-quality-control.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/careers/job-search.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/investors/shares-and-bonds.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/research/innovation-center.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/displays.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/optoelectronics.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/expertise/general-medicine.html
https://www.emdgroup.com/en/company/who-we-are/healthcare.html/en/investors.html

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: bion3.com
Registry Domain ID: 35148268_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.rrpproxy.net
Registrar URL:
Updated Date: 2017-06-22T12:42:48.0Z
Creation Date: 2000-09-20T17:53:36.0Z
Registrar Registration Expiration Date: 2017-09-20T17:53:36.0Z
Registrar: Key-Systems GmbH
Registrar IANA ID: 269
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +49.68949396850
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Registry Registrant ID: Not Available From Registry
Registrant Name: Domain Administration
Registrant Organization: Merck KGaA
Registrant Street: Frankfurter Str. 250
Registrant City: Darmstadt
Registrant State/Province:
Registrant Postal Code: D-64271
Registrant Country: DE
Registrant Phone: +49.6151725303
Registrant Phone Ext:
Registrant Fax: +49.6151723378
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID: Not Available From Registry
Admin Name: Domain Administration
Admin Organization: Merck KGaA
Admin Street: Frankfurter Str. 250
Admin City: Darmstadt
Admin State/Province:
Admin Postal Code: D-64271
Admin Country: DE
Admin Phone: +49.6151725303
Admin Phone Ext:
Admin Fax: +49.6151723378
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID: Not Available From Registry
Tech Name: Merck KGaA Web Administration
Tech Organization: Merck KGaA
Tech Street: Frankfurter Str. 250
Tech City: Darmstadt
Tech Postal Code: 64293
Tech State/Province: HE
Tech Country: DE
Tech Phone: +49.6151722964
Tech Phone Ext:
Tech Fax: +49.615172912964
Tech Fax Ext:
Tech Email: [email protected]
Registry Billing ID: Not Available From Registry
Billing Name: Billing Department BrandShelter
Billing Organization: Key-Systems GmbH
Billing Street: Im Oberen Werk 1
Billing City: Sankt Ingbert
Billing State/Province: Saarland
Billing Postal Code: 66386
Billing Country: DE
Billing Phone: +49.68949396850
Billing Phone Ext:
Billing Fax: +49.68949396851
Billing Fax Ext:
Billing Email: [email protected]
Name Server: ns1.brandshelter.com
Name Server: ns2.brandshelter.de
Name Server: ns3.brandshelter.info
Name Server: ns4.brandshelter.net
Name Server: ns5.brandshelter.us
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: https://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-07-22T04:50:52.0Z <<<

For more information on Whois status codes, please visit https://www.icann.org/epp


This data is provided by
for information purposes, and to assist persons obtaining information
about or related to domain name registration records.
does not guarantee its accuracy.
By submitting a WHOIS query, you agree that you will use this data
only for lawful purposes and that, under no circumstances, you will
use this data to
1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via E-mail
(spam) or
2) enable high volume, automated, electronic processes that apply
to this WHOIS server.
These terms may be changed without prior notice.
By submitting this query, you agree to abide by this policy.

  REGISTRAR KEY-SYSTEMS GMBH

  REFERRER http://www.key-systems.net

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =bion3.com

  PORT 43

  SERVER whois.rrpproxy.net

  ARGS bion3.com

  PORT 43

  TYPE domain

DOMAIN

  NAME bion3.com

NSERVER

  NS1.BRANDSHELTER.COM 178.33.33.199

  NS2.BRANDSHELTER.DE 188.165.164.191

  NS3.BRANDSHELTER.INFO 94.23.156.156

  NS4.BRANDSHELTER.NET 192.95.19.131

  NS5.BRANDSHELTER.US 192.95.17.188

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

  CHANGED 2017-06-22

  CREATED 2000-09-20

  EXPIRES 2017-09-20

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.ubion3.com
  • www.7bion3.com
  • www.hbion3.com
  • www.kbion3.com
  • www.jbion3.com
  • www.ibion3.com
  • www.8bion3.com
  • www.ybion3.com
  • www.bion3ebc.com
  • www.bion3ebc.com
  • www.bion33bc.com
  • www.bion3wbc.com
  • www.bion3sbc.com
  • www.bion3#bc.com
  • www.bion3dbc.com
  • www.bion3fbc.com
  • www.bion3&bc.com
  • www.bion3rbc.com
  • www.urlw4ebc.com
  • www.bion34bc.com
  • www.bion3c.com
  • www.bion3bc.com
  • www.bion3vc.com
  • www.bion3vbc.com
  • www.bion3vc.com
  • www.bion3 c.com
  • www.bion3 bc.com
  • www.bion3 c.com
  • www.bion3gc.com
  • www.bion3gbc.com
  • www.bion3gc.com
  • www.bion3jc.com
  • www.bion3jbc.com
  • www.bion3jc.com
  • www.bion3nc.com
  • www.bion3nbc.com
  • www.bion3nc.com
  • www.bion3hc.com
  • www.bion3hbc.com
  • www.bion3hc.com
  • www.bion3.com
  • www.bion3c.com
  • www.bion3x.com
  • www.bion3xc.com
  • www.bion3x.com
  • www.bion3f.com
  • www.bion3fc.com
  • www.bion3f.com
  • www.bion3v.com
  • www.bion3vc.com
  • www.bion3v.com
  • www.bion3d.com
  • www.bion3dc.com
  • www.bion3d.com
  • www.bion3cb.com
  • www.bion3com
  • www.bion3..com
  • www.bion3/com
  • www.bion3/.com
  • www.bion3./com
  • www.bion3ncom
  • www.bion3n.com
  • www.bion3.ncom
  • www.bion3;com
  • www.bion3;.com
  • www.bion3.;com
  • www.bion3lcom
  • www.bion3l.com
  • www.bion3.lcom
  • www.bion3 com
  • www.bion3 .com
  • www.bion3. com
  • www.bion3,com
  • www.bion3,.com
  • www.bion3.,com
  • www.bion3mcom
  • www.bion3m.com
  • www.bion3.mcom
  • www.bion3.ccom
  • www.bion3.om
  • www.bion3.ccom
  • www.bion3.xom
  • www.bion3.xcom
  • www.bion3.cxom
  • www.bion3.fom
  • www.bion3.fcom
  • www.bion3.cfom
  • www.bion3.vom
  • www.bion3.vcom
  • www.bion3.cvom
  • www.bion3.dom
  • www.bion3.dcom
  • www.bion3.cdom
  • www.bion3c.om
  • www.bion3.cm
  • www.bion3.coom
  • www.bion3.cpm
  • www.bion3.cpom
  • www.bion3.copm
  • www.bion3.cim
  • www.bion3.ciom
  • www.bion3.coim
  • www.bion3.ckm
  • www.bion3.ckom
  • www.bion3.cokm
  • www.bion3.clm
  • www.bion3.clom
  • www.bion3.colm
  • www.bion3.c0m
  • www.bion3.c0om
  • www.bion3.co0m
  • www.bion3.c:m
  • www.bion3.c:om
  • www.bion3.co:m
  • www.bion3.c9m
  • www.bion3.c9om
  • www.bion3.co9m
  • www.bion3.ocm
  • www.bion3.co
  • bion3.comm
  • www.bion3.con
  • www.bion3.conm
  • bion3.comn
  • www.bion3.col
  • www.bion3.colm
  • bion3.coml
  • www.bion3.co
  • www.bion3.co m
  • bion3.com
  • www.bion3.cok
  • www.bion3.cokm
  • bion3.comk
  • www.bion3.co,
  • www.bion3.co,m
  • bion3.com,
  • www.bion3.coj
  • www.bion3.cojm
  • bion3.comj
  • www.bion3.cmo
Show All Mistakes Hide All Mistakes